HARP - Harpoon Therapeutics, Inc.

QQQ $ 440.32 $ 0.07 (0.02 %)

DIA $ 388.70 $ 0.29 (0.07 %)

SPY $ 517.26 $ 0.57 (0.11 %)

TLT $ 90.79 $ 0.55 (0.61 %)

GLD $ 214.23 $ -0.99 (-0.46 %)

Previous Close

$ 23.01

Open

$ 23.00

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 23.00 - $ 23.02

52 Week Range

$ 3.11 - $ 23.21

Volume

6,624,340

Average Volume

Market Cap

90.84M

Beta (5Y Monthly)

$ 1.09

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-09-2023	09-30-2023	10-Q
2	08-09-2023	06-30-2023	10-Q
3	05-11-2023	03-31-2023	10-Q
4	03-27-2023	12-31-2022	10-K
5	11-14-2022	09-30-2022	10-Q
6	08-10-2022	06-30-2022	10-Q
7	05-12-2022	03-31-2022	10-Q
8	03-10-2022	12-31-2021	10-K
9	11-10-2021	09-30-2021	10-Q
10	08-05-2021	06-30-2021	10-Q
11	05-06-2021	03-31-2021	10-Q
12	03-10-2021	12-31-2020	10-K
13	11-04-2020	09-30-2020	10-Q
14	08-05-2020	06-30-2020	10-Q
15	05-06-2020	03-31-2020	10-Q
16	03-12-2020	12-31-2019	10-K
17	11-06-2019	09-30-2019	10-Q
18	08-05-2019	06-30-2019	10-Q
19	05-09-2019	03-31-2019	10-Q
20	03-14-2019	12-31-2018	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oppenheimer Maintains Outperform on Harpoo...
03/26/2024 14:03:41

Oppenheimer analyst Hartaj Singh maintains Harpoon Therapeutics (NASDAQ:HARP) from Outperform to Outperform.

Analyst Scoreboard: 4 Ratings For Harpoon ...
02/26/2024 17:00:46

merck-posts-surprise-quarterly-profit-against-an-expected-loss-oncology-and-vaccines-drive-growth

Merck Posts Surprise Quarterly Profit Agai...
02/01/2024 15:43:50

Merck reports fourth quarter 2023 sales of $14.63 billion, a 6% YoY increase, beating estimates. Explore oncology, vaccines, an...

investor-optimism-around-keytruda-drives-merck-stock-to-golden-cross-ahead-of-earnings

Investor Optimism Around Keytruda Drives M...
01/29/2024 19:05:12

Merck stock has gained 20% since Nov. 28; a technical signal suggests the rally isn't over. Keytruda approvals also drive o...

Peeling Back The Layers: Exploring Harpoon...
01/16/2024 21:00:39

TD Cowen Downgrades Harpoon Therapeutics t...
01/16/2024 19:49:09

TD Cowen analyst Tara Bancroft downgrades Harpoon Therapeutics (NASDAQ:HARP) from Outperform to Market Perform.

dow-surges-over-100-points-commercial-metals-posts-upbeat-q1-results

Dow Surges Over 100 Points; Commercial Met...
01/08/2024 19:33:00

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow ...

HC Wainwright & Co. Downgrades Harpoon The...
01/08/2024 18:41:57

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Harpoon Therapeutics (NASDAQ:HARP) from Buy to Neutral and...

why-rxsight-shares-are-trading-higher-by-20-here-are-other-stocks-moving-in-mondays-mid-day-session

Why RxSight Shares Are Trading Higher By 2...
01/08/2024 18:36:30

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
01/08/2024 17:30:59

Crude Oil Falls Sharply; Ambrx Biopharma S...
01/08/2024 17:22:01

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded down...

today-is-cancer-focused-deals-day-johnson--johnson-scoops-up-ambrx-biopharma-as-merck-boosts-cancer-portfolio-with-harpoon-deal

Today Is Cancer-Focused Deals Day: Johnson...
01/08/2024 15:18:52

Monday, Johnson & Johnson (NYSE: JNJ) has agreed to acquire Ambrx Biopharma Inc (NASDAQ: AMAM) in an all-cash merger transa...

Health Care Company Merck & Co Announces A...
01/08/2024 15:10:16

US Stocks Mixed; Nasdaq Jumps Over 100 Points
01/08/2024 15:00:54

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market ope...

Market-Moving News for January 8th
01/08/2024 13:43:28

HARP: 145% | Bloomberg Reported Earlier: Merck Is In Advanced Talks To Buy Harpoon Therapeutics For ~$23/Share ACON: 130% | Ac...

why-lumiradx-shares-are-trading-lower-by-over-30-here-are-20-stocks-moving-premarket

Why LumiraDx Shares Are Trading Lower By O...
01/08/2024 13:20:16

Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading. LumiraDx announced its securities will ...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
01/08/2024 13:05:59

top-3-health-care-stocks-that-may-plunge-in-january

Top 3 Health Care Stocks That May Plunge I...
01/08/2024 13:05:26

As of Jan. 8, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as ...

Merck To Acquire Harpoon Therapeutics For ...
01/08/2024 12:33:55

why-is-cancer-focused-harpoon-therapeutics-stock-shooting-higher-today

Why Is Cancer Focused Harpoon Therapeutics...
01/08/2024 12:04:48

Merck & Co Inc (NYSE: MRK) is reportedly negotiating to purchase cancer drugmaker Harpoon Therapeutics Inc (NASDAQ: